Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

Speakers

  • Catherine E. Lai, MD, MPH | Penn Medicine
  • Elizabeth Olson Hexner, MD | Penn Medicine
  • Pashna N. Mushni, MD | Penn Medicine
  • Daria V. Babushok, MD, PhD | Penn Medicine
  • Ximena Jordan Bruno, MD | Penn Medicine
  • Elise A. Chong, MD | Penn Medicine

Topics

  • Treatment of Patients With Myelofibrosis
  • Current and Future Treatments for Chronic GVHD
  • Treatment Pathways for Patients With PNH
  • Emerging Treatment Standards for MDS
  • Sequencing BTK Inhibitors in CLL
  • Therapeutic Approaches to AML

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Jennifer R. Eads, MD, physician lead, GI Cancer Research, director, National Clinical Trials Network, Abramson Cancer Center, University of Pennsylvania, associate professor, clinical medicine (hematology-oncology), Penn Medicine, Perelman Center for Advanced Medicine
Ben Levy, MD, and Yan Leyfman, MD
BTK Inhibitors in CLL : Second Generation Drugs and Beyond
David L. Porter, MD
David L. Porter, MD, director, Cell Therapy and Transplant, Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Penn Medicine
Carrie L. Kitko, MD
Kara N. Maxwell, MD, PhD
Lori A. Leslie, MD
Kara N. Maxwell, MD, PhD